James O. Armitage's Insider Trades & SAST Disclosures

James O. Armitage's most recent trade in Cardiff Oncology Inc was a trade of 40,565 Stock Options done . Disclosure was reported to the exchange on June 26, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Cardiff Oncology Inc
James O. Armitage Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2025 40,565 187,539 - - Stock Options
Cardiff Oncology Inc
James O. Armitage Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jun 2024 29,700 146,974 - - Stock Options
Cardiff Oncology Inc
James O. Armitage Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 27,700 117,274 - - Stock Options
Cardiff Oncology Inc
James O. Armitage Director Purchase of securities on an exchange or from another person at price $ 1.56 per share. 16 Sep 2022 13,000 13,000 (0%) 0% 1.6 20,233 Common Stock
Cardiff Oncology Inc
James O. Armitage Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2022 26,800 89,574 - - Stock Options
Cardiff Oncology Inc
James O. Armitage Director Purchase of securities on an exchange or from another person at price $ 10.82 per share. 19 Mar 2021 4,000 14,490 (0%) 0% 10.8 43,271 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades